<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>GBIHealth | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2021-01-15T12:04:11+08:00</updated>
  <subtitle>GBI专注于中国市场，为药企、器械企业和其他服务提供商建立多元的市场情报解决方案组合。GBI的高附加值行业信息、新闻和数据服务能力帮助个人和组织做出以数据为驱动的决策，更高效地沟通。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>重磅！辉瑞与上海市疾控中心达成合作，携手建设上海疫苗临床试验基地</title>
    <updated>2021-01-14T18:04:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-14:/s/HcxvIHCDW3iKm1uRdxpzjA</id>
    <link href="https://mp.weixin.qq.com/s/HcxvIHCDW3iKm1uRdxpzjA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>百济神州百泽安获批首项肺癌适应症；绿叶集团瑞欣妥获批上市；礼来VEGFR-2单抗新药晚期胃癌III期临床获成功</title>
    <updated>2021-01-14T18:04:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-14:/s/Gs_NlnUHnfRA6ROTK1WgKw</id>
    <link href="https://mp.weixin.qq.com/s/Gs_NlnUHnfRA6ROTK1WgKw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>DEVINT | 腔镜手术机器人公司术锐获3亿元B轮投资</title>
    <updated>2021-01-14T18:04:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-14:/s/6N2xSy4_nCoqYHvJYdOoaA</id>
    <link href="https://mp.weixin.qq.com/s/6N2xSy4_nCoqYHvJYdOoaA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>核心产品2次上市申请均遭拒  美国医药“独角兽”崩塌</title>
    <updated>2021-01-13T21:52:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-13:/s/QyrwKfC9vtNTTpxsDjiIkQ</id>
    <link href="https://mp.weixin.qq.com/s/QyrwKfC9vtNTTpxsDjiIkQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>百济神州与安进合作药物拟纳入突破性治疗；信达生物达伯舒联合达攸同新适应症上市申请获受理；复宏汉霖CD38单抗临床试验获批</title>
    <updated>2021-01-13T21:52:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-13:/s/Bwyk6Ae5HNuDuoeldWeAJg</id>
    <link href="https://mp.weixin.qq.com/s/Bwyk6Ae5HNuDuoeldWeAJg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>DEVINT | 强生启动未来数字技术QuickFire挑战赛，鼓励药械创新；索诺瓦首推汉莎通助听器，声望听力为大陆区总代理</title>
    <updated>2021-01-13T21:52:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-13:/s/Q-IMBGsavqAYCadzP20ttw</id>
    <link href="https://mp.weixin.qq.com/s/Q-IMBGsavqAYCadzP20ttw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>纳入2020年国家医保目录药品，已有药企自1月1日期开始调价</title>
    <updated>2021-01-12T18:31:41+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-12:/s/Gi3iACWqqed4ZhOsXOLcWQ</id>
    <link href="https://mp.weixin.qq.com/s/Gi3iACWqqed4ZhOsXOLcWQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>信达生物PD-1新适应症上市申请获受理；诺诚健华合作镁信健康，提升奥布替尼可及性；百济神州达成开发实体瘤mRNA疗法合作</title>
    <updated>2021-01-12T18:31:41+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-12:/s/2RqpPWJUNvlz5k_XLwnt_Q</id>
    <link href="https://mp.weixin.qq.com/s/2RqpPWJUNvlz5k_XLwnt_Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>DEVINT | 睿心医疗完成近3亿元B轮融资；人工心脏研发公司心擎医疗获得超亿元B轮融资</title>
    <updated>2021-01-12T18:31:41+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-12:/s/qlffu_xJfl5z1s50qLNpZw</id>
    <link href="https://mp.weixin.qq.com/s/qlffu_xJfl5z1s50qLNpZw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>深度 | 中国创新药发展的未来10年 观点3（连载第五期）</title>
    <updated>2021-01-11T20:33:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-11:/s/wO71sMdqV5d5AwUZ7VmqTw</id>
    <link href="https://mp.weixin.qq.com/s/wO71sMdqV5d5AwUZ7VmqTw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>信达利妥昔单抗纳入上海医保；天士力撤回科创板上市申请；德琪医药多发性骨髓瘤药物引进海南博鳌</title>
    <updated>2021-01-11T20:33:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-11:/s/PdAwQZ0PoVIG2MQVaradYg</id>
    <link href="https://mp.weixin.qq.com/s/PdAwQZ0PoVIG2MQVaradYg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>DEVINT | 数问生物新冠检测试剂盒获欧盟CE-IVD认证及中国出口许可</title>
    <updated>2021-01-11T20:33:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-11:/s/MlEcssDT-jUyJgu3x_pXtg</id>
    <link href="https://mp.weixin.qq.com/s/MlEcssDT-jUyJgu3x_pXtg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020年50个西药获批上市，其中13个已进医保，7个进口，6个国产（含详细名单）</title>
    <updated>2021-01-10T21:45:50+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-10:/s/nORNhNSTOJf0yfU_NXrrww</id>
    <link href="https://mp.weixin.qq.com/s/nORNhNSTOJf0yfU_NXrrww" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>GSK艾滋病新药国内报上市；3款新药拟纳入优先审评；贝达药业申请在港交所上市</title>
    <updated>2021-01-10T21:45:50+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-10:/s/5cxbvjDNzTUVRhC_CeFqZw</id>
    <link href="https://mp.weixin.qq.com/s/5cxbvjDNzTUVRhC_CeFqZw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>DEVINT | 求臻医学与天广实合作肿瘤伴随诊断试剂盒开发；恒升医疗获得近3亿元A轮融资</title>
    <updated>2021-01-10T21:45:50+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-10:/s/FsPiizicF9oWq_guUJB-uw</id>
    <link href="https://mp.weixin.qq.com/s/FsPiizicF9oWq_guUJB-uw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>深度 | 中国创新药发展的未来10年 观点2（连载第四期）</title>
    <updated>2021-01-07T17:43:34+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-07:/s/ik7rqzTMKXDdGyN5YcCAOw</id>
    <link href="https://mp.weixin.qq.com/s/ik7rqzTMKXDdGyN5YcCAOw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>阿斯利康达格列净新适应症获FDA优先审评资格；齐鲁三款产品过评；再鼎医药1.75亿美元获一在研新药大中华区独家权益</title>
    <updated>2021-01-07T17:43:34+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-07:/s/eyVFjYfP1SQieyD6TczXig</id>
    <link href="https://mp.weixin.qq.com/s/eyVFjYfP1SQieyD6TczXig" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>DEVINT | 泛生子合作正大天晴，布局肝癌早筛</title>
    <updated>2021-01-07T17:43:34+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-07:/s/oc82Fiy2dSt--ILR9sfVWw</id>
    <link href="https://mp.weixin.qq.com/s/oc82Fiy2dSt--ILR9sfVWw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>深度 | 中国创新药发展的未来10年 观点1（连载第三期）</title>
    <updated>2021-01-06T20:36:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-06:/s/ZOrX2sGcXo750I_BuPsi8g</id>
    <link href="https://mp.weixin.qq.com/s/ZOrX2sGcXo750I_BuPsi8g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>距获批仅7天，诺诚健华奥布替尼片商业上市！罗氏贝伐珠单抗递交新适应症上市申请；拓臻生物完成8700万美元C轮融资</title>
    <updated>2021-01-06T20:36:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-06:/s/We9G38vV3G8_PQjxyF-YAQ</id>
    <link href="https://mp.weixin.qq.com/s/We9G38vV3G8_PQjxyF-YAQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>